Cyclopentenone: a special moiety for anticancer drug design
Author:
- 1 October 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 17 (9) , 1017-1022
Abstract
The conjugate cyclopent-en-one chemical group is a special moiety for anticancer drugs. Studies on cyclopentenone prostaglandins, clavulones and other compounds have revealed its mechanism of action and a wide spectrum of intracellular targets, ranging from nuclear factors to mitochondria. The introduction of the cyclopentenone moiety into molecules, such as jasmonates and chalcones, has been shown to boost their anticancer potential. In this work, reviewing pertinent up-to-date literature, we have pointed out potentially effective cyclopentenone-bearing compounds for anticancer clinical research and inspiring relationships for future drug design. In particular, it appears that the addition of cyclopentenone groups to target-orienting molecules, in order to inactivate specific proteins in cells, could be a helpful general strategy for the development of novel therapeutic molecules.Keywords
This publication has 35 references indexed in Scilit:
- Solid-Phase Synthesis and Biological Activity of a Combinatorial Cross-Conjugated Dienone LibraryChemistry – A European Journal, 2006
- Jasmonates–a new family of anti-cancer agentsAnti-Cancer Drugs, 2005
- Jasmonates: Novel Anticancer Agents Acting Directly and Selectively on Human Cancer Cell MitochondriaCancer Research, 2005
- Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormonesLeukemia, 2004
- Synthesis and anti-tumor activity of novel combretastatins: combretocyclopentenones and related analoguesBioorganic & Medicinal Chemistry Letters, 2002
- Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cellsOncogene, 2002
- Cyclopentenone prostaglandins: New insights on biological activities and cellular targetsMedicinal Research Reviews, 2001
- 2-Cyclopenten-1-one, a New Inducer of Heat Shock Protein 70 with Antiviral ActivityJournal of Biological Chemistry, 1996
- Intracellular glutathione level modulates the induction of apoptosis by Δ12-prostaglandin J2Prostaglandins, 1996
- Requirement of a reactive α,β-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by “A” series prostaglandinsBiochemical and Biophysical Research Communications, 1985